Cargando…

Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches

[Image: see text] Ferrous ion and 2-oxoglutarate (2OG) oxygenases catalyze the demethylation of N(ε)-methylated lysine residues in histones. Here we report studies on the inhibition of the JMJD2 subfamily of histone demethylases, employing binding analyses by nondenaturing mass spectrometry (MS), dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Nathan R., Woon, Esther C. Y., Kingham, Guy L., King, Oliver N. F., Mecinović, Jasmin, Clifton, Ian J., Ng, Stanley S., Talib-Hardy, Jobina, Oppermann, Udo, McDonough, Michael A., Schofield, Christopher J.
Formato: Texto
Lenguaje:English
Publicado: American Chemical Society 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825117/
https://www.ncbi.nlm.nih.gov/pubmed/20088513
http://dx.doi.org/10.1021/jm901680b
_version_ 1782177783412162560
author Rose, Nathan R.
Woon, Esther C. Y.
Kingham, Guy L.
King, Oliver N. F.
Mecinović, Jasmin
Clifton, Ian J.
Ng, Stanley S.
Talib-Hardy, Jobina
Oppermann, Udo
McDonough, Michael A.
Schofield, Christopher J.
author_facet Rose, Nathan R.
Woon, Esther C. Y.
Kingham, Guy L.
King, Oliver N. F.
Mecinović, Jasmin
Clifton, Ian J.
Ng, Stanley S.
Talib-Hardy, Jobina
Oppermann, Udo
McDonough, Michael A.
Schofield, Christopher J.
author_sort Rose, Nathan R.
collection PubMed
description [Image: see text] Ferrous ion and 2-oxoglutarate (2OG) oxygenases catalyze the demethylation of N(ε)-methylated lysine residues in histones. Here we report studies on the inhibition of the JMJD2 subfamily of histone demethylases, employing binding analyses by nondenaturing mass spectrometry (MS), dynamic combinatorial chemistry coupled to MS, turnover assays, and crystallography. The results of initial binding and inhibition assays directed the production and analysis of a set of N-oxalyl-d-tyrosine derivatives to explore the extent of a subpocket at the JMJD2 active site. Some of the inhibitors were shown to be selective for JMJD2 over the hypoxia-inducible factor prolyl hydroxylase PHD2. A crystal structure of JMJD2A in complex with one of the potent inhibitors was obtained; modeling other inhibitors based on this structure predicts interactions that enable improved inhibition for some compounds.
format Text
id pubmed-2825117
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-28251172010-02-19 Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches Rose, Nathan R. Woon, Esther C. Y. Kingham, Guy L. King, Oliver N. F. Mecinović, Jasmin Clifton, Ian J. Ng, Stanley S. Talib-Hardy, Jobina Oppermann, Udo McDonough, Michael A. Schofield, Christopher J. J Med Chem [Image: see text] Ferrous ion and 2-oxoglutarate (2OG) oxygenases catalyze the demethylation of N(ε)-methylated lysine residues in histones. Here we report studies on the inhibition of the JMJD2 subfamily of histone demethylases, employing binding analyses by nondenaturing mass spectrometry (MS), dynamic combinatorial chemistry coupled to MS, turnover assays, and crystallography. The results of initial binding and inhibition assays directed the production and analysis of a set of N-oxalyl-d-tyrosine derivatives to explore the extent of a subpocket at the JMJD2 active site. Some of the inhibitors were shown to be selective for JMJD2 over the hypoxia-inducible factor prolyl hydroxylase PHD2. A crystal structure of JMJD2A in complex with one of the potent inhibitors was obtained; modeling other inhibitors based on this structure predicts interactions that enable improved inhibition for some compounds. American Chemical Society 2010-01-20 2010-02-25 /pmc/articles/PMC2825117/ /pubmed/20088513 http://dx.doi.org/10.1021/jm901680b Text en Copyright © 2010 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
spellingShingle Rose, Nathan R.
Woon, Esther C. Y.
Kingham, Guy L.
King, Oliver N. F.
Mecinović, Jasmin
Clifton, Ian J.
Ng, Stanley S.
Talib-Hardy, Jobina
Oppermann, Udo
McDonough, Michael A.
Schofield, Christopher J.
Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
title Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
title_full Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
title_fullStr Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
title_full_unstemmed Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
title_short Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
title_sort selective inhibitors of the jmjd2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825117/
https://www.ncbi.nlm.nih.gov/pubmed/20088513
http://dx.doi.org/10.1021/jm901680b
work_keys_str_mv AT rosenathanr selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT woonesthercy selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT kinghamguyl selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT kingolivernf selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT mecinovicjasmin selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT cliftonianj selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT ngstanleys selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT talibhardyjobina selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT oppermannudo selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT mcdonoughmichaela selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches
AT schofieldchristopherj selectiveinhibitorsofthejmjd2histonedemethylasescombinednondenaturingmassspectrometricscreeningandcrystallographicapproaches